• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

μ阿片受体突变体T394A消除了阿片类药物介导的腺苷酸环化酶超激活。

Mu opioid receptor mutant, T394A, abolishes opioid-mediated adenylyl cyclase superactivation.

作者信息

Wang Hongyan, Guang Wei, Barbier Elisabeth, Shapiro Paul, Wang Jia Bei

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA.

出版信息

Neuroreport. 2007 Dec 3;18(18):1969-73. doi: 10.1097/WNR.0b013e3282f228b2.

DOI:10.1097/WNR.0b013e3282f228b2
PMID:18007196
Abstract

This study was to characterize the effects of a point-mutant at C-terminal of mu opioid receptor (MOR), namely MOR T394A, in chronic opioid-induced cellular responses. After 18 h of exposure to [D-Ala, N-Me-Phe, Gly-ol] enkephalin (DAMGO), adenylyl cyclase (AC) superactivation, a hallmark for the cellular adaptive response after chronic opioid stimulation, was observed in the cells expressing wild-type receptor, but was totally abolished in the cells expressing MOR T394A. Receptor phosphorylation was also attenuated in cells with MOR T394A after prolonged preexposure to agonist. Furthermore, MAP kinase kinase-1 (MKK1) overexpression was able to rescue AC superactivation in cells with MOR T394A, but showed no effect in the wild-type MOR-expressing cells. These results indicated that the amino acid T394 at C-terminus of MOR played a critical role in chronic agonist-induced AC superactivation and receptor phosphorylation.

摘要

本研究旨在表征μ阿片受体(MOR)C末端的一个点突变体,即MOR T394A,在慢性阿片类药物诱导的细胞反应中的作用。在用[D-丙氨酸,N-甲基苯丙氨酸,甘氨醇]脑啡肽(DAMGO)处理18小时后,在表达野生型受体的细胞中观察到腺苷酸环化酶(AC)超活化,这是慢性阿片类药物刺激后细胞适应性反应的一个标志,但在表达MOR T394A的细胞中完全消失。在长时间预暴露于激动剂后,MOR T394A细胞中的受体磷酸化也减弱。此外,丝裂原活化蛋白激酶激酶-1(MKK1)的过表达能够挽救MOR T394A细胞中的AC超活化,但对表达野生型MOR的细胞没有影响。这些结果表明,MOR C末端的氨基酸T394在慢性激动剂诱导的AC超活化和受体磷酸化中起关键作用。

相似文献

1
Mu opioid receptor mutant, T394A, abolishes opioid-mediated adenylyl cyclase superactivation.μ阿片受体突变体T394A消除了阿片类药物介导的腺苷酸环化酶超激活。
Neuroreport. 2007 Dec 3;18(18):1969-73. doi: 10.1097/WNR.0b013e3282f228b2.
2
Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling.[D-丙氨酸2,N-甲基苯丙氨酸4,甘氨酸5-醇]-脑啡肽(DAMGO)和CTAP(D-苯丙氨酸-半胱氨酸-酪氨酸-D-色氨酸-精氨酸-苏氨酸-青霉胺-苏氨酸-NH2)对腺苷酸环化酶活性的双重作用:对μ-阿片受体Gs偶联的影响
J Pharmacol Exp Ther. 2004 Jul;310(1):256-62. doi: 10.1124/jpet.104.066837. Epub 2004 Mar 2.
3
Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization.长期使用阿片类激动剂治疗诱导的腺苷酸环化酶超活化依赖于定位于脂筏内的受体,且与受体内化无关。
Mol Pharmacol. 2006 Apr;69(4):1421-32. doi: 10.1124/mol.105.020024. Epub 2006 Jan 13.
4
Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic delta-opioid agonist treatment.在慢性δ-阿片受体激动剂治疗后,汇聚的蛋白激酶途径介导腺苷酸环化酶超活化。
J Pharmacol Exp Ther. 2003 Jul;306(1):109-15. doi: 10.1124/jpet.103.049643. Epub 2003 Mar 26.
5
Plasticity of adenylyl cyclase-related signaling sequelae after long-term morphine treatment.长期吗啡治疗后腺苷酸环化酶相关信号后遗症的可塑性。
Mol Pharmacol. 2008 Mar;73(3):868-79. doi: 10.1124/mol.107.042184. Epub 2007 Nov 28.
6
Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation.激动剂对κ阿片受体介导的腺苷酸环化酶超活化的差异作用:腺苷酸环化酶超活化与激动剂诱导的磷酸化、脱敏、内化和下调无关。
J Pharmacol Exp Ther. 2003 Dec;307(3):1127-34. doi: 10.1124/jpet.103.055814. Epub 2003 Oct 13.
7
Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.G蛋白信号蛋白的内源性调节剂可减少C6细胞中的μ-阿片受体脱敏、下调及腺苷酸环化酶耐受性。
J Pharmacol Exp Ther. 2005 Feb;312(2):809-15. doi: 10.1124/jpet.104.074641. Epub 2004 Sep 21.
8
Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain.μ-阿片样受体的配体选择性激活:通过第三细胞内环结构域的缺失和单氨基酸突变得以证实。
J Pharmacol Exp Ther. 2003 Jun;305(3):909-18. doi: 10.1124/jpet.102.046219. Epub 2003 Mar 6.
9
Opioid mu receptor activation inhibits sodium currents in prefrontal cortical neurons via a protein kinase A- and C-dependent mechanism.阿片类μ受体激活通过一种蛋白激酶A和C依赖性机制抑制前额叶皮质神经元中的钠电流。
Brain Res. 2006 Jun 13;1094(1):92-106. doi: 10.1016/j.brainres.2006.03.119. Epub 2006 Jun 2.
10
Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.阿片肽受体研究。16. 慢性吗啡改变表达克隆的μ阿片受体的细胞中的G蛋白功能。
Synapse. 2003 Jan;47(1):1-9. doi: 10.1002/syn.10144.

引用本文的文献

1
Synthesis of the Mechanisms of Opioid Tolerance: Do We Still Say NO?阿片类药物耐受性机制的综合研究:我们仍要说“不”吗?
Cell Mol Neurobiol. 2021 Jul;41(5):927-948. doi: 10.1007/s10571-021-01065-8. Epub 2021 Mar 11.
2
T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.μ阿片受体上的T394A突变可阻断阿片耐受并增加小鼠对海洛因自我给药的易感性。
J Neurosci. 2016 Oct 5;36(40):10392-10403. doi: 10.1523/JNEUROSCI.0603-16.2016.
3
Analgesic tolerance of opioid agonists in mutant mu-opioid receptors expressed in sensory neurons following intrathecal plasmid gene delivery.
鞘内质粒基因转染感觉神经元表达的突变型 μ 阿片受体后,阿片激动剂的镇痛耐受。
Mol Pain. 2013 Dec 5;9:63. doi: 10.1186/1744-8069-9-63.
4
Mu opioids and their receptors: evolution of a concept.μ 阿片类药物及其受体:概念的演变。
Pharmacol Rev. 2013 Sep 27;65(4):1257-317. doi: 10.1124/pr.112.007138. Print 2013.
5
Identification of phosphorylation sites in the COOH-terminal tail of the μ-opioid receptor.鉴定 μ 阿片受体羧基末端尾部的磷酸化位点。
J Neurochem. 2013 Jan;124(2):189-99. doi: 10.1111/jnc.12071. Epub 2012 Nov 30.
6
Neutral antagonist activity of naltrexone and 6beta-naltrexol in naïve and opioid-dependent C6 cells expressing a mu-opioid receptor.纳曲酮和6β-纳曲醇在表达μ阿片受体的未接触过阿片类药物及阿片类药物依赖的C6细胞中的中性拮抗活性。
Br J Pharmacol. 2009 Apr;156(7):1044-53. doi: 10.1111/j.1476-5381.2008.00035.x. Epub 2009 Feb 13.